대한부인종양학회

최신 논문

총 게시글 : 196

Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update 2026-06-24 VIEW : 6
Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma: The European Society of Gynaecological Oncology Consensus Statements 2026-06-24 VIEW : 5
ESGO Consensus Statement on endometrial cancer prevention, risk reduction strategies, and management of women with Lynch syndrome 2026-06-24 VIEW : 3
Assessment of probiotic and prebiotic use in gynecologic cancer patients: a systematic review 2026-06-24 VIEW : 1
Dostarlimab and niraparib in primary advanced ovarian cancer 2026-03-17 VIEW : 8
Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial 2026-03-17 VIEW : 3
Self-Acupressure for Fatigue in Patients Surviving Ovarian Cancer 2026-03-17 VIEW : 2
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial 2026-03-17 VIEW : 3
Impact of bilateral oophorectomy on survival among patients undergoing radical hysterectomy for cervical adenocarcinoma: a National Cancer Database analysis 2026-03-17 VIEW : 8
Long-Term Prospective Cohort Study of Cervical Cancer Screening Using Triage of Women who Are Human Papillomavirus–Positive With Dual Stain and Human Papillomavirus Genotyping 2026-03-17 VIEW : 5
Women’s Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening 2026-03-17 VIEW : 4
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial 2026-03-17 VIEW : 2
Sentinel node mapping with carbon nanoparticles versus lymphadenectomy in early cervical cancer 2026-03-17 VIEW : 7
Nivolumab and Ipilimumab in Advanced Mismatch Repair-Deficient/Microsatellite Instability-High Noncolorectal Cancers: A Nonrandomized Clinical Trial 2026-03-17 VIEW : 3
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial 2026-03-17 VIEW : 2

1
2
3
4
5
6
7
8
9
10
...
13
14